A new type of blood test in the U.S. is starting to transform cancer treatment, sparing some patients the surgical and needle biopsies long needed to guide their care.
May 11, 2015
0
7
Women diagnosed with breast cancer who previously breastfed their babies had a 30 percent overall decreased risk of the disease recurring, according to a new Kaiser Permanente study published in the Journal of the National ...
Apr 28, 2015
0
15
Women diagnosed with breast cancer are often told not to eat soyfoods or soy-based supplements because they can interfere with anti-estrogen treatment. But new research being presented at the American Association for Cancer ...
Apr 20, 2015
0
14
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Apr 15, 2015
0
16
Breast cancer patients who undergo a mastectomy should receive subsequent radiation treatment if their cancer has spread to four or more nearby lymph nodes, however, according to a new study, only 65 percent of these women ...
Feb 9, 2015
0
37
The risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer remains very small, but it is twice as high as previously reported, according to results of a new study led by researchers ...
Dec 22, 2014
0
0
Among premenopausal women with early-stage, hormone receptor-positive breast cancer, adding ovarian suppression to tamoxifen reduced breast cancer recurrence for those who had previously received chemotherapy and remained ...
Dec 12, 2014
0
0
Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...
Nov 21, 2014
0
0
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor–positive tumors, about one-half of patients fail to take their medications as directed. A study by ...
Oct 28, 2014
0
0
Discontinuation and nonadherence were higher among breast cancer patients taking brand name aromatase inhibitors (BAIs) vs generic AIs (GAIs), according to a new study published October 27 in the JNCI: Journal of the National ...
Oct 27, 2014
0
0
